116 related articles for article (PubMed ID: 33974057)
21. Statin Prescribing Practices in the Comprehensive Care for HIV-Infected Patients.
Kelly SG; Krueger KM; Grant JL; Penugonda S; Feinstein MJ; Taiwo BO; Achenbach CJ
J Acquir Immune Defic Syndr; 2017 Sep; 76(1):e26-e29. PubMed ID: 28520617
[No Abstract] [Full Text] [Related]
22. Association of Primary Care Providers' Beliefs of Statins for Primary Prevention and Statin Prescription.
Clough JD; Martin SS; Navar AM; Lin L; Hardy NC; Rogers U; Curtis LH
J Am Heart Assoc; 2019 Feb; 8(3):e010241. PubMed ID: 30681391
[TBL] [Abstract][Full Text] [Related]
23. Statin prescribing among hypertensive patients in southwest Nigeria: findings and implications for the future.
Akunne OO; Godman B; Adedapo AD; Truter I; Fadare J
J Comp Eff Res; 2016 May; 5(3):281-8. PubMed ID: 27097045
[TBL] [Abstract][Full Text] [Related]
24. Evaluating an implementation strategy in cardiovascular prevention to improve prescribing of statins in Germany: an intention to treat analysis.
Keller H; Hirsch O; Kaufmann-Kolle P; Krones T; Becker A; Sönnichsen AC; Baum E; Donner-Banzhoff N
BMC Public Health; 2013 Jul; 13():623. PubMed ID: 23819600
[TBL] [Abstract][Full Text] [Related]
25. Variation in minimum desired cardiovascular disease-free longevity benefit from statin and antihypertensive medications: a cross-sectional study of patient and primary care physician perspectives.
Jaspers NEM; Visseren FLJ; Numans ME; Smulders YM; van Loenen Martinet FA; van der Graaf Y; Dorresteijn JAN
BMJ Open; 2018 May; 8(5):e021309. PubMed ID: 29804065
[TBL] [Abstract][Full Text] [Related]
26. Excessive range of statin dose in Western Australian primary care.
Dimmitt SB; Moran A; Scartozzi M; Stampfer HG; Warren JB
Intern Med J; 2015 Aug; 45(8):860-3. PubMed ID: 25871923
[TBL] [Abstract][Full Text] [Related]
27. Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population.
Bakhai A; Rigney U; Hollis S; Emmas C
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):485-93. PubMed ID: 22237927
[TBL] [Abstract][Full Text] [Related]
28. Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry.
Lowenstern A; Li S; Navar AM; Virani S; Lee LV; Louie MJ; Peterson ED; Wang TY
Am Heart J; 2018 Jun; 200():118-124. PubMed ID: 29898839
[TBL] [Abstract][Full Text] [Related]
29. Association of Primary Care Clinic Appointment Time With Opioid Prescribing.
Neprash HT; Barnett ML
JAMA Netw Open; 2019 Aug; 2(8):e1910373. PubMed ID: 31469396
[TBL] [Abstract][Full Text] [Related]
30. [Transferring to the practice the results of the clinical trials with statins: from the relative risk to the absolute risk].
Martín-Luján F; Baldrich-Justel M; Bejarano-Romero F
Med Clin (Barc); 2005 Dec; 125(20):799. PubMed ID: 16373038
[No Abstract] [Full Text] [Related]
31. Statin use in Canadians: trends, determinants and persistence.
Neutel CI; Morrison H; Campbell NR; de Groh M
Can J Public Health; 2007; 98(5):412-6. PubMed ID: 17985686
[TBL] [Abstract][Full Text] [Related]
32. Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians.
Rzouq FS; Volk ML; Hatoum HH; Talluri SK; Mummadi RR; Sood GK
Am J Med Sci; 2010 Aug; 340(2):89-93. PubMed ID: 20588181
[TBL] [Abstract][Full Text] [Related]
33. Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia.
Demoz GT; Wahdey S; Kasahun GG; Hagazy K; Kinfe DG; Tasew H; Bahrey D; Niriayo YL
BMC Res Notes; 2019 Jul; 12(1):386. PubMed ID: 31288848
[TBL] [Abstract][Full Text] [Related]
34. Statin prescribing patterns in a cohort of cancer patients with poor prognosis.
Bayliss EA; Bronsert MR; Reifler LM; Ellis JL; Steiner JF; McQuillen DB; Fairclough DL
J Palliat Med; 2013 Apr; 16(4):412-8. PubMed ID: 23305190
[TBL] [Abstract][Full Text] [Related]
35. Impact of changing reimbursement criteria on statin treatment patterns among patients with atherosclerotic cardiovascular disease or cardiovascular risk factors.
Hsu CY; Chen WJ; Chen HM; Tsai HY; Hsiao FY
J Clin Pharm Ther; 2021 Apr; 46(2):415-423. PubMed ID: 33180353
[TBL] [Abstract][Full Text] [Related]
36. Inequality in provision of medical care in Sweden: a case of social epidemiological hypochondria?
Kaufman JS
J Epidemiol Community Health; 2010 Aug; 64(8):651-2. PubMed ID: 20670974
[No Abstract] [Full Text] [Related]
37. Statin prescribing according to gender, age and indication: what about the benefit-risk balance?
Wallach-Kildemoes H; Stovring H; Holme Hansen E; Howse K; Pétursson H
J Eval Clin Pract; 2016 Apr; 22(2):235-46. PubMed ID: 26446680
[TBL] [Abstract][Full Text] [Related]
38. Cholesterol drug lowers LDL-C levels but again fails to show clinical benefit.
Mitka M
JAMA; 2010 Jan; 303(3):211-2. PubMed ID: 20085945
[No Abstract] [Full Text] [Related]
39. Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care.
Krüger K; Leppkes N; Gehrke-Beck S; Herrmann W; Algharably EA; Kreutz R; Heintze C; Filler I
Br J Gen Pract; 2018 Jun; 68(671):e401-e407. PubMed ID: 29686133
[TBL] [Abstract][Full Text] [Related]
40. Statin Prescribing Patterns: An Analysis of Data From Patients With Diabetes in the National Hospital Ambulatory Medical Care Survey Outpatient Department and National Ambulatory Medical Care Survey Databases, 2005-2010.
Pauff BR; Jiroutek MR; Holland MA; Sutton BS
Clin Ther; 2015 Jun; 37(6):1329-39. PubMed ID: 25869626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]